Treatment of Prostate Cancer in Vitro and in Vivo With 2-5a-Anti-Telomerase RNA Component(New Era of Antisense Therapy)

Japanese Journal of Urology - Japan
doi 10.5980/jpnjurol.91.171_3
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors

Unknown

Publisher

Japanese Urological Association

Related search

Combination Therapy of Malignant Glioma Cells With 2-5a-Antisense Telomerase RNA and Recombinant Adenovirus P53

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2000English

Combined Effect of 2-5a-Linked Antisense Against Telomerase RNA and Conventional Therapies on Human Malignant Glioma Cells in Vitro and in Vivo

International Journal of Oncology
Cancer ResearchOncology
2007English

Telomerase Activity and Expression of Telomerase RNA Component and Telomerase Catalytic Subunit Gene in Cervical Cancer

American Journal of Pathology
Forensic MedicinePathology
1998English

Catalytic Cleavage of an RNA Target by 2–5A Antisense and RNase L

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Enhancement of Anti-Telomerase Immunity Against Prostate Cancer

2005English

Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy

Drug Discovery Today: Therapeutic Strategies
2013English

In Vitro and in Vivo Anti-Cancer Activity of Silymarin on Oral Cancer

Tumor Biology
MedicineCancer Research
2018English

Adenovirus-Mediated Apo(A)-Antisense-Rna Expression Efficiently Inhibits Apo(a) Synthesis in Vitro and in Vivo

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2001English

Antisense Gene Therapy Using Anti-K-Ras and Antitelomerase Oligonucleotides in Colorectal Cancer

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy